Crunching the numbers for AMPH... Refresh in a moment for the full analysis.
Amphastar Pharmaceuticals, Inc. (AMPH)
Healthcare
mixed
$20.37
Updated: 2026-04-12
50
TradeApes Score
hold
Financial Strength
45
Mixed
Operating Trend
48
Mixed
Valuation
50
Mixed
Capital Allocation
50
Mixed
Risk
70
Healthy
Key Findings
+
Free cash flow positive — business generates real spendable cash
−
High leverage — net debt/EBITDA between 3× and 5×
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.